Skip to main content
. 2018 Dec 18;58(8):1141–1144. doi: 10.2169/internalmedicine.1890-18

Figure 1.

Figure 1.

HRCT images at the carina level (A) and at the lower lobe level (B) two months before initiating nintedanib therapy. HRCT images at the carina level (C) and at the lower lobe level (D) four months after starting treatment. HRCT images showed reductions in the areas of ground-glass opacity and consolidation compared with those in the images obtained before treatment.